Department of Pneumology and Critical Care Medicine, Thoraxklinik, University of Heidelberg gGmbH, Heidelberg, Germany.
Respiration. 2010;79(1):54-60. doi: 10.1159/000232394. Epub 2009 Jul 31.
Electromagnetic navigation has been approved for use as an adjunct to standard bronchoscopy. The diagnostic yield varies depending on the size of the lesion and successful navigation to the lesion.
The performance of two different biopsy tools, i.e. catheter aspiration and forceps biopsy, in the diagnosis of small pulmonary nodules (SPN) guided by electromagnetic navigational bronchoscopy (ENB) was examined.
54 patients referred for suspected lung cancer underwent ENB and 55 SPN (<3 cm) were sampled using both techniques. Endobronchial ultrasound (EBUS) was used to verify the accuracy of target lesion localization by ENB. Primary end points of the study were successful navigation to the lesion and a positive diagnosis. Patients were followed until a definitive diagnosis was obtained.
All 55 lesions were accessed. Two lesions were excluded from data analysis as the patients were lost to follow-up and their diagnoses could not be confirmed. Of the remaining 53 lesions, 40 samples (75.5%) were diagnostic. Compared to forceps biopsy, catheter aspiration was positively correlated with the success rate (36/40 vs. 22/40; p = 0.035). The diagnostic yield was 93% when EBUS verified the lesion location after navigation and only 48% when lesion location was not confirmed. There were no significant complications.
ENB is a useful tool in the evaluation of SPN <3 cm in diameter. For malignant lesions, sampling by catheter aspiration is associated with a higher diagnostic yield than sampling by forceps biopsy alone, in particular when EBUS could not confirm lesion location prior to sampling.
电磁导航已被批准作为标准支气管镜检查的辅助手段。诊断率取决于病变的大小和成功导航到病变的程度。
检查电磁导航支气管镜(ENB)引导下两种不同活检工具(即导管抽吸和活检钳)在小肺结节(SPN)诊断中的性能。
54 例疑似肺癌患者接受 ENB 检查,55 个 SPN(<3cm)采用两种技术进行采样。支气管内超声(EBUS)用于验证 ENB 对目标病变定位的准确性。研究的主要终点是成功导航到病变和阳性诊断。患者随访至获得明确诊断。
所有 55 个病变均被触及。由于患者失访且无法确认其诊断,有 2 个病变被排除在数据分析之外。在剩余的 53 个病变中,40 个样本(75.5%)具有诊断意义。与活检钳相比,导管抽吸与成功率呈正相关(36/40 比 22/40;p=0.035)。导航后 EBUS 验证病变位置时诊断率为 93%,而未确认病变位置时诊断率仅为 48%。无明显并发症。
ENB 是评估直径<3cm 的 SPN 的有用工具。对于恶性病变,与单独使用活检钳采样相比,导管抽吸采样的诊断率更高,尤其是在采样前 EBUS 无法确认病变位置时。